CompletedNot Applicable

Post COVID-19 REspiratory Mechanisms and the Efficacy of a Breathing Exercise Intervention for DYsregulated Breathing

United Kingdom40 participantsStarted 2023-02-10

Plain-language summary

A pilot Study To investigate the efficacy of a breathing intervention for improving persistent breathlessness due to dysregulated breathing following COVID-19 when compared to usual care.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Either hospitalised or non-hospitalised with confirmed COVID-19 acute infection. * Received a comprehensive clinical respiratory assessment * Persisting (\>12 weeks) self-reported breathlessness (on CRQ-D) following COVID-19 and confirmed dysregulated breathing (Nijmegen Questionnaire score NQ \>23) * Age 18 - 80 years of age * Ability to give informed consent * Able to understand and speak English language Exclusion Criteria: * Severe mood disturbance that limits engagement with the intervention and study outcomes * No access to online delivery and/or IT illiterate * Significant diagnosed Myalgic Encephalitis/Fibromyalgia/Chronic Fatigue Syndrome prior to developing COVID-19 * Severe asthma or other chronic lung disease prior to COVID-19

What they're measuring

Breathlessness.

Timeframe: 7 weeks

Function

Timeframe: 7 weeks

Trial details

NCT IDNCT05732571

SponsorUniversity of Nottingham

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-31

View on ClinicalTrials.gov More COVID-19 trials